Yahoo Finance1h
U.S. FDA Removes Clinical Hold on Novavax's COVID-19-Influenza Combination and Stand-alone Influenza Phase 3 Trial
GAITHERSBURG, Md., Nov. 11, 2024 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based ...
Altimmune Appoints Life Sciences Industry Veteran Greg Weaver as Chief Financial Officer
GAITHERSBURG, Md., Nov. 11, 2024 (GLOBE NEWSWIRE) -- . (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced the appointment of Greg Weaver as Chief Financial Officer (CFO), ...